We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Back to Healio WASHINGTON — MELD 3.0 more accurately ...

Adoption of a new version of the Model for End-Stage Liver Disease, known as MELD 3.0, closed the gap in access to liver transplant between men and women, an analysis showed. Since MELD 3.0 was ...

End-stage liver disease patients at lower risk for death in the short term still reaped the substantial benefits of a living-donor liver transplant (LDLT), a case-control study revealed. Compared with ...

Rochester, Minn.-based Mayo Clinic developed an artificial intelligence model using electrocardiogram data that outperformed the current model for ...

SAN DIEGO — Since the adoption of the most recent Model for End-Stage Liver Disease (MELD 3.0) scoring system by the federal Organ Procurement and Transplantation Network (OPTN) in July 2023, the ...

Nov. 5, 2002 (Boston) — A study of 66 people who underwent liver transplantation with a right lobe from a living donor suggests that preoperative Model for Endstage Liver Disease (MELD) scores do not ...

Since the adoption of a new model for assessing the severity of liver disease, women are more likely to be added to the waitlist for a liver transplant, more likely to receive a transplant, and less ...

We were unable to process your request. Please try again later. If you continue to have this issue please contact [email protected]. Waitlist survival at 90 days improved from 86.5% before ...